Please login to the form below

Not currently logged in
Email:
Password:

lenalidomide

This page shows the latest lenalidomide news and features for those working in and with pharma, biotech and healthcare.

GSK preps filings for BCMA-targeting multiple myeloma drug

GSK preps filings for BCMA-targeting multiple myeloma drug

lenalidomide), a proteasome inhibitor such as Takeda’s Velcade (bortezomib), as well as Johnson &Johnson’s anti-CD38 antibody Darzalex (daratumumab).

Latest news

More from news
Approximately 14 fully matching, plus 90 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics